https://www.prnewswire.com/ae/news-releases/yishengbio-announces-pika-recombinant-covid-19-vaccine-received-phase-i-clinical-trial-ind-clearance-from-the-uae-301336132.html
/PRNewswire/ -- YishengBio Co., Ltd ("YishengBio") today announced that it has received IND clearance for PIKA recombinant COVID-19 vaccine to conduct Phase...
phase iannouncespikarecombinantcovid
https://www.news-medical.net/news/20211015/Phase-2-study-shows-safety-and-immunogenicity-of-SARS-CoV-2-recombinant-protein-vaccine.aspx
The results of a phase 2 clinical trial featuring a SARS-CoV-2 recombinant protein vaccine developed by GlaxoSmithKline are reported, demonstrating a favorable...
sars covphasestudyshowssafety
https://www.omicsonline.org/peer-reviewed/analysis-of-mutagenic-potential-of-therapeutic-vaccine-based-on-bpv1-e6-recombinant-protein-combined-with-different-adjuvantsp-97230.html
Analysis of Mutagenic Potential of Therapeutic Vaccine Based on BPV-1 E6 Recombinant Protein Combined with Different Adjuvants Abstract.
therapeutic vaccineanalysismutagenicpotentialbased
https://pubmed.ncbi.nlm.nih.gov/41383761/?utm_source=WordPress&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1bQr69UjXVa0RWWgHOzcn29XPGZnlK70akveDs5L8fL7l7oE7c&fc=20220912113029&ff=20260115155610&v=2.18.0.post22+67771e2
The COVID-19 pandemic has demonstrated the detrimental potential of zoonotic coronavirus transmission to human populations. Effective vaccines capable of...
viral vectordevelopmentrecombinantsinglecycle